home.aspx
 
EVENTS

Medicinal and Pharmaceutical Chemistry
MEDICINAL AND PHARMACEUTICAL CHEMISTRY
December 16-17, 2019
Medicinal Chemistry is the science of design and chemical synthesis focusing mainly on small organic molecules and their development of pharmaceutical agents, or bio-active molecules (drugs). Pharmaceutical Chemistry is the same plus the science of pharmaceutical and biomedical analysis to the synth...

Drug Formulation & Analytical Techniques
DRUG FORMULATION & ANALYTICAL TECHNIQUES
December 16-17, 2019
Pharmaceutical formulation in pharmaceutics is the process in which various chemical substances including the vigorous drug are joined to produce a final medicinal product. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally...

Acceleron Pharma

Acceleron is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to treat serious and rare diseases.

RELATED NEWS


A brain training game could help improve the memory of patients in the very earliest stages of dementia, suggests a study.A brain training game developed by researchers at the University of Cambridge could help improve the memory of patients in the very earliest stages of dementia, suggests a study. Amnestic mild cognitive impairment (aMCI) has been described as the transitional stage between ‘healthy ageing’ and dementia. It is characterised by day-to-day memory difficulties and problems of mot...

READ MORE

NICE has given Bayer’s advanced liver cancer therapy Stivarga (regorafenib) the go-ahead after it undertook a rapid review following earlier guidance that rejected the drug. The medicine is for adults in England and Wales whose liver is well functioning but unable to be surgically removed and who have already taken Bayer’s life-extending medicine Nexavar (sorafenib). In March this year, the National Institute for Health and Care Excellence (NICE) found that regorafenib was less cost-...

READ MORE

Excited by strong phase II data, Novartis is exercising its option to license Akcea Therapeutics’ TQJ230, a treatment to reduce the risk of cardiovascular disease in people living with elevated levels of inherited lipoprotein(a). TQJ230, previously known as AKCEA-APO(a)-LRx, was discovered by Ionis Pharmaceuticals and has been co-developed to date by Akcea and Ionis. In a deal announced in January 2017, Novartis said it would be working with Ionis to license and develop TQJ230 and another ...

READ MORE

Announced that ZALVISO® (sufentanil sublingual tablet system) has been selected for a Red Dot Award in the category of Product Design – Life Sciences and MedicineThe Red Dot Awards in this category are presented to products that display innovative design features that improve or enhance patient experience....

READ MORE

Pharma bosses faced a grilling from the US Senate’s Finance Committee over the high price of branded prescription drugs in the US compared with other developed countries. Appearing before the committee were pharma CEOs including AstraZeneca’s Pascal Soriot, AbbVie’s Richard Gonzalez, and US-based Merck & Co’s Kenneth Frazier. As well as facing pointed questions over pricing, the CEOs also faced criticism over the “thickets” of patents used to block generic...

READ MORE

Reducing the population size of this "reservoir" of infected cells represents the largest challenge for the cure of HIV. Based on these results, study authors believe reducing cellular proliferation could help to deplete the reservoir and potentially lead to a functional cure. Led by Drs. Dan Reeves and Josh Schiffer in the Vaccine and Infectious Diseases Division at Fred Hutchinson Cancer Research Center, the research team combined mathematical models and immunological insight to unde...

READ MORE

EVENTS

Drug Formulation & Analytical Techniques
DRUG FORMULATION & ANALYTICAL TECHNIQUES
December 16-17, 2019
Pharmaceutical formulation in pharmaceutics is the process in which various chemical substances including the vigorous drug are joined to produce a final medicinal product. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally...

International Conference on Metabolic Diseases and Liver Cancer
INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER
December 16-17, 2019
“INTERNATIONAL CONFERENCE ON METABOLIC DISEASES AND LIVER CANCER ’’ is organized in order to bring light and anticipate to the dark sides of human liver cancer and irregular human metabolic diseases which are prevailing worldwide. This conference is effective on all sides as it giv...